Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Inventory (2020 - 2025)

Historic Inventory for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $6.7 million.

  • SOPHiA GENETICS's Inventory rose 313.42% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 313.42%. This contributed to the annual value of $5.9 million for FY2024, which is 947.24% down from last year.
  • Latest data reveals that SOPHiA GENETICS reported Inventory of $6.7 million as of Q3 2025, which was up 313.42% from $6.2 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Inventory ranged from a high of $6.7 million in Q3 2025 and a low of $3.7 million during Q2 2021
  • In the last 5 years, SOPHiA GENETICS's Inventory had a median value of $5.7 million in 2021 and averaged $5.5 million.
  • Per our database at Business Quant, SOPHiA GENETICS's Inventory soared by 6929.67% in 2021 and then crashed by 1963.51% in 2023.
  • SOPHiA GENETICS's Inventory (Quarter) stood at $5.7 million in 2021, then dropped by 10.0% to $5.2 million in 2022, then grew by 25.72% to $6.5 million in 2023, then fell by 9.47% to $5.9 million in 2024, then increased by 13.84% to $6.7 million in 2025.
  • Its last three reported values are $6.7 million in Q3 2025, $6.2 million for Q2 2025, and $5.0 million during Q1 2025.